Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
04/2012
04/04/2012EP2436384A2 Aripiprazole oral solution
04/04/2012EP2436383A1 Oral medicinal composition and oral medicinal capsule having the composition encapsulated therein
04/04/2012EP2436382A1 Pharmaceutical compositions of HDAC inhibitors and chelatable metal compounds, and metal-HDAC inhibitor chelate complexes
04/04/2012EP2436381A1 Crystallization of hydrohalides of pharmaceutical compounds
04/04/2012EP2436379A1 Stable tablet formulation
04/04/2012EP2436377A2 Microspheres with improved bioavailability containing poorly water-soluble drugs, and method for preparing same
04/04/2012EP2436376A1 Cancer cell targeting using nanoparticles
04/04/2012EP2436375A1 Pharmaceutical compositions comprising fentanyl for intranasal delivery
04/04/2012EP2436374A1 Ovule for vaginal administration of arasertaconazole
04/04/2012EP2436275A1 Lipid composition for improving brain function
04/04/2012EP2435571A2 Treatment of antiviral gene related diseases by inhibition of natural antisense transcript to an antiviral gene
04/04/2012EP2435570A1 Differentiation therapy for sarcomas
04/04/2012EP2435504A1 Flavonoid hydrogel
04/04/2012EP2435463A2 Steroide anionic compounds, method of their production, usage and pharmaceutical preparation involving them
04/04/2012EP2435462A1 Novel glucocorticoid receptor agonists
04/04/2012EP2435460A1 Ketolide compounds having antimicrobial activity
04/04/2012EP2435445A1 Inhibitors of c-met protein kinase
04/04/2012EP2435444A1 Substituted pyrazole inhibitors of c-met protein kinase
04/04/2012EP2435443A1 Aminopyrazole triazolothiadiazole inhibitors of c-met protien kinase
04/04/2012EP2435438A1 Bicyclic pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
04/04/2012EP2435437A1 Processes for the preparation of substituted tetrahydro beta-carbolines
04/04/2012EP2435436A1 Pyrimidine inhibitors of kinase activity
04/04/2012EP2435435A1 Pyrimidine inhibitors of kinase activity
04/04/2012EP2435434A1 Heterocyclic urea derivatives and methods of use thereof
04/04/2012EP2435433A1 (dihydro) imidazoiso (5, 1-a) quinolines as fsh receptor agonists for the treatment of fertility disorders
04/04/2012EP2435431A1 Substituted piperidines
04/04/2012EP2435430A1 Substituted 3-(1,2,4-oxadiazol-5-yl)-5-phenylpiperidines
04/04/2012EP2435429A1 Hepatitis c virus inhibitors
04/04/2012EP2435427A1 Substituted piperidines
04/04/2012EP2435426A1 BENZOXAZEPINES AS INHIBITORS OF PI3K/m TOR AND METHODS OF THEIR USE AND MANUFACTURE
04/04/2012EP2435425A1 Hepatitis c virus inhibitors
04/04/2012EP2435424A1 Antiviral compounds composed of three linked aryl moieties to treat diseases such as hepatitis c
04/04/2012EP2435423A1 Substituted benzotriazines and quinoxalines as inhibitors of p7os6 kinase
04/04/2012EP2435422A1 Pyrimidine inhibitors of kinase activity
04/04/2012EP2435421A1 Antiviral compounds composed of three aligned aryl moieties to treat diseases such as hepatitis c
04/04/2012EP2435420A1 Pyrazinylpyrazoles
04/04/2012EP2435416A2 Tetrahydropyranochromene gamma secretase inhibitors
04/04/2012EP2435414A1 Piperazine, piperidine and tetrahydropyridine derivatives and their pharmaceutical use
04/04/2012EP2435412A1 Disaccharin, difumaric acid, di-l-hydroxy-2-naphthoic acid and mono-benzoic acid salts of 4- (dimethylamin0)butyl 2- (4- ( (2-amino-4-methyl-6- (pentylamino) pyrimidin- 5 -yl) methyl) phenyl)acetate
04/04/2012EP2435411A1 2, 4 -diaminopyrimidines for the treatment of diseases characterised by excessive or abnormal cell proliferation
04/04/2012EP2435410A2 Lxr modulators
04/04/2012EP2435409A1 Substituted aminopropionic derivatives as neprilysin inhibitors
04/04/2012EP2435407A1 Aryl substituted carboxamide derivatives as calcium or sodium channel blockers
04/04/2012EP2435406A1 Resolution of (±)-methyl phenyl[4-[4-[[[4'-(trifluoromethyl)-2-biphenylyl]carbonyl]amino]phenyl]-1-piperidinyl]acetate
04/04/2012EP2435405A1 Substituted piperidines
04/04/2012EP2435404A1 Novel calcium sensing receptor modulating compounds and pharmaceutical use thereof
04/04/2012EP2435403A2 Thiocolchicine derivatives, method of making and methods of use thereof
04/04/2012EP2435402A2 Substituted aminobutyric derivatives as neprilysin inhibitors
04/04/2012EP2435398A1 Process for the production of benzofurans
04/04/2012EP2435394A1 Novel anthraquinone derivatives
04/04/2012EP2435387A1 Method of providing neuroprotection using substituted porphyrins
04/04/2012EP2435082A1 Transdermal therapeutic system having controlled active substance flow comprising a basic reacting oxide
04/04/2012EP2435080A2 Pharmaceutical compositions for the treatment of pain
04/04/2012EP2435053A1 Polyal drug conjugates comprising variable rate-releasing linkers
04/04/2012EP2435052A1 Solid oral dosage forms of lamivudine
04/04/2012EP2435051A1 Oxazolidinone containing dimer compounds, compositions and methods to make and use
04/04/2012EP2435050A2 Methods for administration and formulations for the treatment of regional adipose tissue
04/04/2012EP2435049A1 Pharmaceutical composition comprising prostaglandin derivatives for use in modulating claudin mediated functions and in the treatment of dermatological disorders
04/04/2012EP2435048A1 Radiolabeled pde10 inhibitors
04/04/2012EP2435047A1 Angina treatment
04/04/2012EP2435046A1 Heterocyclic compounds for the treatment of stress-related conditions
04/04/2012EP2435045A2 Injectable combination of adrenergic receptor agonists with fillers, for decreasing skin reactions due to injection
04/04/2012EP2435044A1 Method of treating sleep disorders using the combination of eplivanserin and zolpidem
04/04/2012EP2435043A1 3-alkyl-5-fluoroindole derivatives as myeloperoxidase inhibitors
04/04/2012EP2435042A1 Method for preparing hollow particles, and uses thereof
04/04/2012EP2435041A1 Therapeutic combination comprising a plk1 inhibitor and an antineoplastic agent
04/04/2012EP2435040A2 N,n-diarylurea compounds and n,n'-diarylthiourea compounds as inhibitors of translation initiation
04/04/2012EP2435039A2 Combination of a leucine source and an omega-3 unsaturated fatty acid source for use in the treatment of hypercalcaemia
04/04/2012EP2435038A1 Combination therapy for the treatment of multiple myeloma using cep-18770 together with bortezomib or mephalan
04/04/2012EP2435037A1 Hiv protease inhibitors
04/04/2012EP2435036A2 Ammoniumcarboxylates
04/04/2012EP2435035A1 Methods of enhancing selective serotonin reuptake inhibitor effects in mammals
04/04/2012EP2435034A1 Use of anthracene derivatives as anti-infectives
04/04/2012EP2435033A1 Methods for treating type 2 diabetes in patients resistant to previous treatment with other anti-diabetic drugs employing an sglt2 inhibitor and compositions thereof
04/04/2012EP2435027A2 Reduction of flake-like aggregation in nanoparticulate active agent compositions
04/04/2012EP2435026A1 Treatment of tissue adhesion
04/04/2012EP2435023A2 Compositon for plumonary delivery of long-agting muscarinic antagonists and long long-acting beta 2 adrenergic receptor agonists and associated methods and systems
04/04/2012EP2435022A2 Self-microemulsifying mitotane composition
04/04/2012EP2435021A2 Use of a glycosaminoglycan fixed combination and chewable composition comprising said fixed combination
04/04/2012EP2435019A1 Dodeca-2e,4e-diene amides and their use as medicaments and cosmetics
04/04/2012EP2434911A1 Green tea extracts of improved bioavailability
04/04/2012EP2434895A1 Organic compounds
04/04/2012EP2434892A1 Azole antifungal compositions
04/04/2012EP2434891A1 Methods for treating cancer and non-neoplastic conditions
04/04/2012EP2434890A1 Iap inhibitors
04/04/2012EP2434889A1 Iap inhibitors
04/04/2012EP2434885A1 Alkoxy tetrahydro-pyridopyrimidine pde10 inhibitors
04/04/2012EP2280959B1 4-amino-indazoles
04/04/2012EP2271340B1 Pharmaceutical preparation comprising stephaglabrin sulfate for treating demyelinating diseases of the nervous system and for promoting restoration of the myelin sheath of nerve fibers
04/04/2012EP2257283B9 L-citrulline for treating erectile dysfunction
04/04/2012EP2251011B1 Solid preparation for oral administration
04/04/2012EP2240438B1 2-methylene-20-methyl-19,24,25,26,27-pentanor-vitamin d analogs
04/04/2012EP2217228B1 Solid pharmaceutical composition comprising tamsulosin
04/04/2012EP2212322B1 Quinolizidinone m1 receptor positive allosteric modulators
04/04/2012EP2207531B1 Self-emulsifying pharmaceutical compositions of rhein or diacerein
04/04/2012EP2097420B1 Spiroketone inhibitors of acetyl-coa carboxylase
04/04/2012EP2069296B1 2-methylene-(20s,25s)-19,27-dinor-(22e)-vitamin d analogs
04/04/2012EP2021327B1 Antidiabetic bicyclic compounds
04/04/2012EP1990343B1 Azaindoles
04/04/2012EP1979341B1 Trisubstituted amine compound
1 ... 1288 1289 1290 1291 1292 1293 1294 1295 1296 1297 1298 1299 1300 1301 1302 1303 1304 1305 1306 1307 1308 ... 7860